Purchase Order 75D30121P11641
Award Date
6/24/21
Potential Completion Date
8/18/21
Potential Value
$94K
Federal Agency
CDC Pittsburgh
Awardee
Luminex Corp
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $248,758.07 definitive contract award to Luminex Corp, a manufacturer of biological testing technologies, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract is for the purchase of an instrument that can detect multiple analytes without the use of lasers, which require more frequent and expensive calibration. Luminex has provided similar products and services to the CDC and other federal agencies in the past, including immunology services, laboratory...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...
This is a $7,717 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the provision of a LUMINEX 200 service and does not have a set-aside designation. Luminex often serves as a prime contractor delivering specialized multiplexing systems that support clinical testing programs and biomedical research efforts across federal agencies,...
This federal contract award is for an XMAP SARS-COV-2 Multi-Antigen IgG Assay, with a ceiling value of $96,587.93, awarded to Luminex Corp by the Centers for Disease Control and Prevention (CDC) on May 7, 2021. The contract is a firm fixed-price purchase order with a completion date of July 9, 2021. Luminex Corp is the prime contractor and no set-aside was used. This award is associated with the CDC's efforts to respond to the Coronavirus COVID-19 public health emergency. Luminex Corp is a...
The Centers for Disease Control and Prevention (CDC) awarded a $79,711 firm-fixed-price purchase order contract to Luminex Corporation for annual services. The contract has an ultimate completion date of April 30, 2026. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and often serves as a prime contractor delivering specialized multiplexing systems to federal agencies. This contract is not designated as a set-aside requirement. Luminex...
This is a $20,791.54 firm-fixed price purchase order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of MICROSPHERE, MAGPLEXAVIDIN, REG 026, 1ML to the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract has a completion date of September 30, 2024 and was awarded on September 12, 2024. There is no set-aside designation for this award. Luminex has provided various diagnostic testing...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
This is a $248,971.98 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of Luminex Beads, with no set-aside designation. Luminex is a prime contractor that provides specialized multiplex diagnostic platforms, assays, reagents, and services to federal agencies including the CDC, VA, DHA,...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...